Device / Technology News

RSS

Intarcia presents ITCA 650 Phase 2 study results at 70th ADA

Intarcia Therapeutics, Inc. presented today the results of a phase 2 clinical study of ITCA 650 (DUROS® continuous subcutaneous delivery of exenatide) for the treatment of type 2 diabetes as a late-breaker at the Annual Conference of the American Diabetes Association in Orlando, FL (June 25-29, 2010). Results of the phase 2 study demonstrated substantial reductions in HbA1c and body weight during the 12 weeks of treatment with ITCA 650 at both the 20 mcg/day and 40 mcg/day doses.

28 Jun 2010

Harris leverages CONNECT solution to enhance capabilities of Bidirectional Health Information Exchange interface

Harris Corporation, as a subcontractor to Evolvent Technologies, Inc., is helping to improve the quality of military patient care provided by enhancing the capabilities of the Bidirectional Health Information Exchange (BHIE) interface. The exchange is a health enterprise integration capability employed by the Department of Defense (DoD) and the Department of Veterans Affairs (VA) to securely share patient information between agencies.

28 Jun 2010

Greenway to provide physician's infrastructure solutions to St. Cloud Medical Group

Greenway Medical Technologies, Inc. is partnering with St. Cloud Medical Group to provide its single-database electronic health record (EHR), practice management and interoperability solution PrimeSuite®, online portal PrimePatient® and remote clinic PrimeMobile™ to St. Cloud's primary care, urgent care, occupational health, surgical, pediatrics, pain management, and OB/GYN services.

28 Jun 2010

World's leading pharma services industry events to held at Frankfurt in 2011

Leading events organiser UBM International Media today announced that its flagship CPhI Worldwide tradeshow will return to Frankfurt, Germany for 2011. Along with co-hosted events - P-MEC Europe for equipment, machinery and technology; ICSE for contract services and packaging; and BioPh Europe for the biopharma sector - the world's leading pharma services industry events will be held at Messe Frankfurt, from Tuesday 25 to Thursday 27 October.

28 Jun 2010

Sunridge International delivers 60 PNT Units and 10,000 disposable rings to BV of China

Sunridge International, announced today that it has completed production and delivery of 60 PNT Units and 10,000 disposable rings to its exclusive distributor, Beijing Vision World Trading Company (BV) of China.

28 Jun 2010

Health Canada approves Solta Medical's Thermage CPT, Fraxel re:store Dual systems

Solta Medical, Inc., the pioneer in fractional resurfacing and non-invasive skin tightening and a market leader in aesthetic skin treatments, today announced Health Canada approval of its Thermage CPT™ and Fraxel re:store® Dual systems. These products are now available to physicians in Canada. In the fall of 2009, the company received U.S. FDA clearance to market and sell both the Thermage CPT and Fraxel re:store Dual systems. Both systems are now available in over 100 countries worldwide.

28 Jun 2010

MagForce's Nano-Cancer therapy receives European regulatory approval

Following two decades of intensive research and development efforts, MagForce Nanotechnologies AG, a Berlin-based medical technology company founded in 1997, has received European regulatory approval for its Nano-Cancer® therapy.

28 Jun 2010

Bayonne Medical Center implements Picis ED PulseCheck ahead of schedule

Picis announced today that Bayonne Medical Center, Bayonne, NJ, has successfully deployed Picis ED PulseCheck™, part of the CareSuite® family of high-acuity solutions, two months ahead of schedule. This aggressive implementation is aimed at helping clinicians in the emergency department (ED) better manage information and the process of treating over 28,000 ED patients annually.

28 Jun 2010

AMP comments on barriers to market for molecular diagnostic tests at FDA CDRH meeting

Yesterday, the Association for Molecular Pathology (AMP) gave public comments at the FDA's Center for Devices and Radiological Health (CDRH) Council meeting on Medical Device Innovation: Barriers to Market for Molecular Diagnostic Tests.

28 Jun 2010

FUJINON restructured into two subsidiaries

FUJIFILM Holdings America Corporation, today announced that FUJINON INC. will be restructured into two subsidiaries - one will report into FUJIFILM North America Corporation and the other into FUJIFILM Medical Systems U.S.A., Inc. This restructuring of Fujinon into two subsidiary companies will support Fujifilm's objective of strengthening its sales organizations to realize future growth.

28 Jun 2010

Medicare turns to more comprehensive tools to find fraud

Federal Times: The Recovery Board, which oversees the $275 billion economic stimulus package that was approved by the federal government in 2009, is using a software platform from Palantir Technologies, based in Palo Alto, Calif. "The software tool analyzes information contained on various government-maintained databases — GSA's list of suspended or debarred contractors, the Treasury Department's financial crimes network and other law enforcement records — along with open-source data such as newspaper articles, lawsuits and other public documents.

28 Jun 2010

FDA grants Abbott 510(k) clearance to market molecular diagnostic test for detection of chlamydia, gonorrhea

Abbott announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia, including a new variant strain of chlamydia recently discovered in Sweden.

28 Jun 2010

Instant processing of insurance claims possible during doctor visit

The New York Times has a consumer health column on programs that would process a patient's insurance claim: "Here's how it could work: A claim is generated and submitted electronically before you finish tying your shoes. By the time you reach the checkout desk, your doctor has received a payment commitment from your insurance company, just as Visa and MasterCard provide to a merchant after a customer swipes a card. It's not fantasy.

28 Jun 2010

Emerald, FORMA sign strategic partnership for structure-based design of cancer drug candidates

Emerald BioStructures, a leading provider of integrated structural biology services, and FORMA Therapeutics, a drug discovery company, today announced the signing of a strategic partnership for the structure-based design of cancer drug candidates for FORMA's pipeline.

28 Jun 2010

Conmed signs agreement with City of Roanoke to provide correctional facility health care services

Conmed Healthcare Management, Inc., a leading full service provider of correctional facility healthcare services to county detention centers, today announced that it has signed an agreement with the City of Roanoke, VA, for an initial three-year term with options for two one-year extensions which are at the City's option.

28 Jun 2010

Masimo granted FDA clearance for Pronto-7 noninvasive hemoglobin spot-check testing device

Masimo, the inventor of Masimo Rainbow Pulse CO-Oximetry™, Masimo Rainbow Acoustic Monitoring™, and Masimo SET® Measure-Through Motion and Low Perfusion pulse oximetry, today announced FDA 510(k) clearance for the Pronto-7™—a new handheld device designed for quick and easy noninvasive hemoglobin (SpHb®) spot-check testing, along with SpO2, pulse rate, and perfusion index, in virtually any environment.

28 Jun 2010

Scientists use PGS method to analyse chromosomal status of eggs

The efficacy of preimplantation genetic screening has been one of the most hotly disputed subjects in assisted reproduction over the past few years. The European Society of Human Reproduction and Embryology PGS Task Force has now shown, in its groundbreaking proof of principle study, that screening of polar bodies (small cells that are the by-product of egg development), is a reliable method to analyse the chromosomal status of an egg.

28 Jun 2010

Quick-Med Technologies announces application for EPA registration of Stay Fresh technology

Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, today announced its application for U.S. Environmental Protection Agency registration of the Company's proprietary Stay Fresh antimicrobial textiles technology.

28 Jun 2010

Study demonstrates effectiveness of pre-emptive pain management protocol using pregabalin in urologic surgery

Reporting in the journal Urology, researchers at Thomas Jefferson University have found that a pre-emptive multimodal pain regimen that included pregabalin (Lyrica) decreased the use of opioid analgesics in patients undergoing robotic-assisted laparoscopic radical prostatectomy.

28 Jun 2010

Zila introduces angled exam mirror as part of ViziLite Plus oral lesion identification and marking system

Zila, leader in the prevention and detection of oral diseases, today introduced an angled exam mirror as part of the ViziLite Plus oral lesion identification and marking system. The autoclavable mirror attaches to the top of the ViziLite Plus lightstick retractor, enhancing dental professionals' ability to see oral lesions during a comprehensive oral cancer screening procedure.

28 Jun 2010

Device / Technology News

Intarcia presents ITCA 650 Phase 2 study results at 70th ADA

Harris leverages CONNECT solution to enhance capabilities of Bidirectional Health Information Exchange interface

Greenway to provide physician's infrastructure solutions to St. Cloud Medical Group

World's leading pharma services industry events to held at Frankfurt in 2011

Sunridge International delivers 60 PNT Units and 10,000 disposable rings to BV of China

Health Canada approves Solta Medical's Thermage CPT, Fraxel re:store Dual systems

MagForce's Nano-Cancer therapy receives European regulatory approval

Bayonne Medical Center implements Picis ED PulseCheck ahead of schedule

AMP comments on barriers to market for molecular diagnostic tests at FDA CDRH meeting

FUJINON restructured into two subsidiaries

Medicare turns to more comprehensive tools to find fraud

FDA grants Abbott 510(k) clearance to market molecular diagnostic test for detection of chlamydia, gonorrhea

Instant processing of insurance claims possible during doctor visit

Emerald, FORMA sign strategic partnership for structure-based design of cancer drug candidates

Conmed signs agreement with City of Roanoke to provide correctional facility health care services

Masimo granted FDA clearance for Pronto-7 noninvasive hemoglobin spot-check testing device

Scientists use PGS method to analyse chromosomal status of eggs

Quick-Med Technologies announces application for EPA registration of Stay Fresh technology

Study demonstrates effectiveness of pre-emptive pain management protocol using pregabalin in urologic surgery

Zila introduces angled exam mirror as part of ViziLite Plus oral lesion identification and marking system

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News